[Prevention of anthracycline cardiotoxicity].
Rossetti
Riccardo
R
D000368:Aged; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D002316:Cardiotonic Agents / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D004337:Drug Carriers; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D016032:Randomized Controlled Trials as Topic; D011929:Razoxane / Q000627:therapeutic use; D012307:Risk Factors
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D002316:Cardiotonic Agents; D004337:Drug Carriers; D008081:Liposomes; D011929:Razoxane